A news website on Indian venture capital, private equity, mergers and acquisitions

Visit VC Circle

CVCI, Everest Capital Invest In Nectar Lifesciences

Posted on August 25, 2008

Citi Venture Capital International (CVCI) and Everest Capital (M) Ltd have invested an undisclosed amount in pharmaceutical major Nectar Lifesciences. The Chandigarh-based pharma company also plans to raise an additional $50 million through the issue of securities in international markets via GDRs/ ADRs/ or any other international offering. Nectar will take the approval of shareholders an extra ordinary general meeting on September 16, the company said informing the BSE. While CVCI is a private equity firm, Everest Capital is a hedge fund. read more...

Original article link


venture capital